4/1
04:32 pm
plse
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/28
04:19 pm
plse
Pulse Biosciences Announces Plans to Initiate a Rights Offering [Yahoo! Finance]
Medium
Report
Pulse Biosciences Announces Plans to Initiate a Rights Offering [Yahoo! Finance]
3/28
04:19 pm
plse
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results [Yahoo! Finance]
Medium
Report
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results [Yahoo! Finance]
3/28
04:12 pm
plse
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
Low
Report
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
3/28
04:10 pm
plse
Pulse Biosciences Announces Plans to Initiate a Rights Offering
Medium
Report
Pulse Biosciences Announces Plans to Initiate a Rights Offering
3/14
04:21 pm
plse
Pulse Biosciences Schedules Fourth Quarter & Full Year 2023 Financial Results Conference Call for March 28, 2024 [Yahoo! Finance]
Low
Report
Pulse Biosciences Schedules Fourth Quarter & Full Year 2023 Financial Results Conference Call for March 28, 2024 [Yahoo! Finance]
3/14
04:05 pm
plse
Pulse Biosciences Schedules Fourth Quarter & Full Year 2023 Financial Results Conference Call for March 28, 2024
Low
Report
Pulse Biosciences Schedules Fourth Quarter & Full Year 2023 Financial Results Conference Call for March 28, 2024
3/8
01:25 pm
plse
Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System [Yahoo! Finance]
Low
Report
Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System [Yahoo! Finance]
3/8
01:17 pm
plse
Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System
Low
Report
Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System
2/14
08:10 am
plse
Pulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility Study [Yahoo! Finance]
High
Report
Pulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility Study [Yahoo! Finance]
2/14
08:00 am
plse
Pulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility Study
High
Report
Pulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility Study
2/2
10:11 am
plse
Companies Like Pulse Biosciences (NASDAQ:PLSE) Are In A Position To Invest In Growth [Yahoo! Finance]
Low
Report
Companies Like Pulse Biosciences (NASDAQ:PLSE) Are In A Position To Invest In Growth [Yahoo! Finance]
1/31
08:19 am
plse
Pulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF Symposium [Yahoo! Finance]
Low
Report
Pulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF Symposium [Yahoo! Finance]
1/31
08:00 am
plse
Pulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF Symposium
Low
Report
Pulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF Symposium